Skip to main content
Caplight Logo









iReprogram, Inc.

iReprogram, Inc.

Private
Ann Arbor, MichiganHealthcare & Life Scienceshttps://ireprogram.com/

Last Round

Early Stage

VC

Aug 13, 2026

Total Funding Raised

$256,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

iReprogram, Inc. is a biotechnology company that provides a bioinformatics platform for direct cell reprogramming and the development of personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

cell reprogrammingcomputational biologytechbiodigital twinsprecision medicinein-silicodrug discoverytranscription factorbioinformaticscell trans-differentiationHypergraph Analysis ToolboxHATregenerative therapyAI-enabled biologygenomic analysisAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iReprogram, Inc. Comparables

Compare iReprogram, Inc. with similar companies based on industry and business-model similarity.

iReprogram, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mogrify
92%
GC Therapeutics
82%
Shift Bioscience
78%

iReprogram, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCAug 13, 2026
GrantFeb 15, 2021

Key People

Founding team and executive leadership

Sarvajit Sinha

Chief Technology Officer

Executive Team

iReprogram, Inc. Investors

Notable investors and investment history

iReprogram, Inc. investors
InvestorRounds
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 13, 2026

    Raised an early stage venture capital round.

  • Oct 14, 2025

    Grew 43% QoQ from 7 to 10 employees.

iReprogram, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iReprogram, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iReprogram, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAnn Arbor, Michigan
Employee Range11
Year Founded2017
Last FundingAug 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?